|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.525 GBX | +3.39% |
|
-1.61% | -77.24% |
| May. 10 | Shield Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Apr. 30 | EARNINGS AND TRADING: Software Circle & Beximco report higher revenue | AN |
Shield Therapeutics plc, announces that Jose A. Menoyo, M.D., is joining Shield's Senior Executive Team as Vice President and Chief Medical Officer with immediate effect. For further details click here.
Back to newsAttachments
Disclaimer
Shield Therapeutics plc published this content on 27 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 September 2021 09:11:02 UTC.
| 1st Jan change | Capi. | |
|---|---|---|
| -77.24% | 14.92M | |
| +3.91% | 109B | |
| +10.87% | 105B | |
| +1.28% | 22.25B | |
| -13.14% | 22.09B | |
| -7.05% | 18.68B | |
| -38.36% | 17.58B | |
| -10.66% | 16.85B | |
| +3.75% | 13.76B | |
| +36.70% | 12.46B |
SHIELD THERAPEUTICS PLC 